We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+7.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$599M
AUM Growth
-$329M
Cap. Flow
-$373M
Cap. Flow %
-62.19%
Top 10 Hldgs %
20.16%
Holding
5,616
New
928
Increased
1,578
Reduced
1,974
Closed
1,071

Sector Composition

Rank Sector Weight
1 Financials 7.99%
2 Industrials 6.24%
3 Technology 5.5%
4 Consumer Discretionary 4.94%
5 Energy 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRS icon
3101
TriMas Corp
TRS
$1.44B
$9K ﹤0.01%
291
-6,515
-96% -$198K
TSEM icon
3102
Tower Semiconductor
TSEM
$28.5B
$9K ﹤0.01%
+1,604
New +$7.59K
VCYT icon
3103
Veracyte
VCYT
$3.8B
$9K ﹤0.01%
+600
New +$7.81K
VOC icon
3104
VOC Energy
VOC
$51.9M
$9K ﹤0.01%
646
-72
-10% -$1.15K
VTWG icon
3105
Vanguard Russell 2000 Growth ETF
VTWG
$1.55B
$9K ﹤0.01%
96
+68
+243% +$6.42K
VUG icon
3106
Vanguard Morningstar Growth ETF
VUG
$230B
$9K ﹤0.01%
600
-168
-22% -$2.48K
WINA icon
3107
Winmark
WINA
$1.32B
$9K ﹤0.01%
100
-469
-82% -$36.9K
WTBA icon
3108
West Bancorporation
WTBA
$485M
$9K ﹤0.01%
572
+372
+186% +$5.38K
AIFC
3109
AI Financial Corp
AIFC
$61.3M
$9K ﹤0.01%
+652
New +$10.2K
QVCGB
3110
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$9K ﹤0.01%
8
+4
+100% +$4.47K
ENG
3111
DELISTED
ENGlobal Corp
ENG
$9K ﹤0.01%
+799
New +$8.55K
PCTI
3112
DELISTED
PCTEL, Inc. Common Stock
PCTI
$9K ﹤0.01%
917
+543
+145% +$5.13K
SOFO
3113
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
$9K ﹤0.01%
888
+788
+788% +$7.65K
MLVF
3114
DELISTED
Malvern Bancorp, Inc.
MLVF
$9K ﹤0.01%
825
+720
+686% +$8.58K
FMO
3115
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$9K ﹤0.01%
72
-457
-86% -$56.5K
ALSK
3116
DELISTED
Alaska Communications Systems
ALSK
$9K ﹤0.01%
+4,107
New +$9.46K
IMMU
3117
DELISTED
Immunomedics Inc
IMMU
$9K ﹤0.01%
1,852
-380
-17% -$1.69K
CROP
3118
DELISTED
IQ Global Agribusiness Small Cap ETF
CROP
$9K ﹤0.01%
+340
New +$9.37K
TTPH
3119
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$9K ﹤0.01%
34
-224
-87% -$53.4K
CASM
3120
DELISTED
CAS Medical Systems, Inc.
CASM
$9K ﹤0.01%
+5,237
New +$8.17K
MSF
3121
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
$9K ﹤0.01%
560
+460
+460% +$7.06K
JONE
3122
DELISTED
Jones Energy, Inc.
JONE
$9K ﹤0.01%
33
-288
-90% -$80.9K
ANCB
3123
DELISTED
Anchor Bancorp
ANCB
$9K ﹤0.01%
+490
New +$8.28K
KST
3124
DELISTED
Deutsche Strategic Income Trust
KST
$9K ﹤0.01%
665
+505
+316% +$6.66K
AYT
3125
DELISTED
iPath GEMS Asia 8 ETN
AYT
$9K ﹤0.01%
+200
New +$9.13K

Similar funds

Tower Research Capital (TRC)'s Q4 2013 Portfolio in Review

As of Q4 2013, Tower Research Capital (TRC) held 5,616 positions worth $599M, down 35% from $928M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Tower Research Capital (TRC) withdrew a net $373M in Q4 2013, closing 1,071 positions and reducing 1,974 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8% of assets, down from 9.8% a quarter earlier, followed by Industrials and Technology.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $12.7M.

  • Tower Research Capital (TRC)'s largest Q4 2013 buy was iShares Russell 1000 ETF: 122,985 shares worth $12.7M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2013, an estimated $37.9M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2013 reduction was Apple, cutting an estimated $17.6M.
  • Tower Research Capital (TRC) fully exited iShares US Real Estate ETF in Q4 2013, selling an estimated $15M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 20% of its $599M portfolio in Q4 2013.
  • Tower Research Capital (TRC) opened 928 new positions and closed 1,071 in Q4 2013.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $599M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2013, filed 31 Jan 2014.